ABC008

AssetAntibody

Monoclonal antibody targeting killer cell lectin-like receptor G1 (KLRG1) to deplete cytotoxic T cells

Stage
Phase 2
Modality
Antibody
Target
Inflammation
Indications
1
Trials
1
Developers
1

Indications

1
  • Targets and what it contains3
  • Owner and partners1
  • Trials1
  • Evidence for its targets3
  • Competitors9
  • Aging relevance2

Every asset’s record: target, stage, trials and the evidence behind it.

See Pro

Updated 7 Oct 2026 · 1 source

Assets